2010
Breast Cancer Adjuvant Chemotherapy Decisions in Older Women: The Role of Patient Preference and Interactions With Physicians
Mandelblatt JS, Sheppard VB, Hurria A, Kimmick G, Isaacs C, Taylor KL, Kornblith AB, Noone AM, Luta G, Tallarico M, Barry WT, Hunegs L, Zon R, Naughton M, Winer E, Hudis C, Edge SB, Cohen HJ, Muss H. Breast Cancer Adjuvant Chemotherapy Decisions in Older Women: The Role of Patient Preference and Interactions With Physicians. Journal Of Clinical Oncology 2010, 28: 3146-3153. PMID: 20516438, PMCID: PMC2903313, DOI: 10.1200/jco.2009.24.3295.Peer-Reviewed Original ResearchConceptsChemotherapy usePatient preferencesChemotherapy decisionsOlder womenCooperative group sitesAdjuvant chemotherapy decisionsNonmetastatic breast cancerHigher patient ratingsTimes higher oddsPatient ageChemotherapy ratesPatient interviewsProvider communicationPatient ratingsBreast cancerPhysician surveyHigher oddsChemotherapyLogistic regressionWomenLimited dataWomen's preferencesImportant correlatesGroupComorbidities
2005
Economic outcomes of breast cancer survivorship: CALGB study 79804
Hensley ML, Dowell J, Herndon JE, Winer E, Stark N, Weeks JC, Paskett E. Economic outcomes of breast cancer survivorship: CALGB study 79804. Breast Cancer Research And Treatment 2005, 91: 153-161. PMID: 15868443, DOI: 10.1007/s10549-004-6497-9.Peer-Reviewed Original ResearchConceptsBreast cancer survivorsBreast cancerMedical oncologistsCancer survivorsMedical oncologyLong-term breast cancer survivorsStage II breast cancerAnnual direct medical costsPatient self-reported dataDisease-free survivorsLong-term outcomesDirect medical costsBreast cancer survivorshipFollow-up variesMedical resourcesMedian annual costPercentage of survivorsLow incomeAdjuvant chemotherapyCancer specialistsCancer survivorshipTumor markersMedical costsYoung survivorsYounger age